Jim cramer senses a 'Fake out' in rumored AstraZeneca, Bristol Myers Squibb $400 billion mega-merger Benzinga 14h Benzinga 14h Article paywall
AstraZeneca and Bristol-Myers Squibb: Megamerger reports leave us scratching our heads MorningStar.com 11h MorningStar.com 11h
Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb Proactive Investors (US) 15h Proactive Investors (US) 15h
A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030 Drug Discovery & Development 03:26
AstraZeneca/BMS Merger Would Be Biopharma’s Biggest, By Far Scrip Pharma Intelligence 21:43 Mon, 03 Aug
Evening digest: Amazon tops $3T, AstraZeneca Bristol Myers merger talks hit shares Invezz 21:06 Mon, 03 Aug
AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus Benzinga 18:15 Mon, 03 Aug Article paywall